Could a simple test replace the scope for Barrett's esophagus screening?
NCT ID NCT05778851
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a non-endoscopic device (EsoCheck) and a biomarker test (EsoGuard) can help doctors decide when to refer patients for a standard upper endoscopy to screen for Barrett's esophagus. 97 doctors reviewed patient cases and made referral decisions, first without and then with the EsoGuard results. The goal was to see if the test changes how often doctors recommend endoscopy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETT ESOPHAGUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lucid Diagnostics
New York, New York, 10017, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which biopsy method best spots early esophageal cancer?
- New cutting tool may outperform heat therapy for Barrett's esophagus
- Scarless procedure may keep precancerous esophagus changes from returning
- Freezing out cancer risk: new balloon treatment for Barrett's esophagus
- Spit test may spot reflux risk after gastric sleeve surgery
- Spit test could spot esophagus condition before it turns cancerous